ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on leukemia: chemo plus targeted drug, with or without transplant
Disease control OngoingThis study is for people with a fast-growing blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It combines a strong chemotherapy regimen (Hyper-CVAD) with a targeted drug (dasatinib) and, for some patients, a donor stem cell transplant. …
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:43 UTC
-
Could a cancer drug boost chemo for tough blood cancers?
Disease control OngoingThis study tests whether adding the drug bortezomib to standard chemotherapy helps children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. About 847 participants will receive either standard chemo alone or chemo plus bo…
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:01 UTC